JW Pharmaceutical Corp
KRX:001060
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
JW Pharmaceutical Corp
Inventory
JW Pharmaceutical Corp
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
JW Pharmaceutical Corp
KRX:001060
|
Inventory
₩109.9B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
2%
|
CAGR 10-Years
3%
|
|
|
Yuhan Corp
KRX:000100
|
Inventory
₩372.8B
|
CAGR 3-Years
11%
|
CAGR 5-Years
8%
|
CAGR 10-Years
4%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Inventory
₩100.2B
|
CAGR 3-Years
3%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Inventory
₩338.8B
|
CAGR 3-Years
8%
|
CAGR 5-Years
2%
|
CAGR 10-Years
8%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Inventory
₩47.8B
|
CAGR 3-Years
15%
|
CAGR 5-Years
14%
|
CAGR 10-Years
10%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Inventory
₩22.7B
|
CAGR 3-Years
41%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
JW Pharmaceutical Corp
Glance View
JW PHARMACEUTICAL Corp. engages in the development, manufacture, and sale of pharmaceuticals. The company is headquartered in Seoul, Seoul. The firm mainly produces and sells drugs including supplying protein amino acids in blood, blood and fluid substitutes, hyperlipidemia agents, electrolyte additives, angina pectoris agents, rheumatoid arthritis drugs, perfusion fluid, prostatic hypertrophy drugs, hepatic coma drugs, and iron injections, among others. The firm also researches and develops anticancer drugs.
See Also
What is JW Pharmaceutical Corp's Inventory?
Inventory
109.9B
KRW
Based on the financial report for Dec 31, 2025, JW Pharmaceutical Corp's Inventory amounts to 109.9B KRW.
What is JW Pharmaceutical Corp's Inventory growth rate?
Inventory CAGR 10Y
3%
Over the last year, the Inventory growth was -2%. The average annual Inventory growth rates for JW Pharmaceutical Corp have been -1% over the past three years , 2% over the past five years , and 3% over the past ten years .
